• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ON-X LIFE TECHNOLOGIES, INC. ON-X ASCENDING AORTIC 23; HEART-VALVE, MECHANICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ON-X LIFE TECHNOLOGIES, INC. ON-X ASCENDING AORTIC 23; HEART-VALVE, MECHANICAL Back to Search Results
Model Number ONXAAP-23
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Death (1802)
Event Date 07/31/2018
Event Type  Death  
Manufacturer Narrative
This investigation is currently ongoing.Any additional information will be provided in the follow-up report.
 
Event Description
According to the operative notes, patient died during surgery.
 
Manufacturer Narrative
A review of the available information was performed.The manufacturing records for the onxaap-23 sn [serial number] (b)(4) were reviewed and it was confirmed that all records were controlled, available for review, and met all specifications.All lots passed functional testing and met release specifications.(b)(6) male patient implanted with onxaap-23 sn (b)(4) on (b)(6) 2018 indicated for ascending aortic dissection involving via emergent procedure finding "extensive aortic dissection all the way down to the aortic valve with severe ai on intraoperative tee prior to cardiopulmonary bypass [cpb]." the onxaap-23 was implanted and patient was weaned from cpb.The patient died same day intraoperatively.Op notes state "bleeding initially appeared to be ceasing and there was good cardiac rhythm and good indices" but then "bleeding became apparent somewhere posteriorly at the proximal anastomosis area.Multiple sutures were applied trying to stop the bleeding.This was unsuccessful.The patient developed bradycardia and a pea." it is possible that the death was due to the trauma of surgery, but there is no objective evidence to indicate what contribution, if any, the valve or the surgery had to the cause of death.Surgical death is a rare, but recognized potential complication associated with aortic valve replacement [instructions for use].As of 2016, the sts database indicated an operative mortality of 2% for aortic valve replacement procedures [sts].There is no evidence to indicate what, if any, relationship the valve had to the death of the patient.No further action is warranted at this time.
 
Event Description
According to the operative notes, patient died during surgery.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ON-X ASCENDING AORTIC 23
Type of Device
HEART-VALVE, MECHANICAL
Manufacturer (Section D)
ON-X LIFE TECHNOLOGIES, INC.
1300 e. anderson ln., bldg. b
austin TX 78752
Manufacturer (Section G)
ON-X LIFE TECHNOLOGIES, INC.
1300 e. anderson ln., bldg. b
austin TX 78752
Manufacturer Contact
rochelle maney
1655 roberts blvd., nw
kennesaw, GA 30144
7704193355
MDR Report Key7852116
MDR Text Key119411157
Report Number1649833-2018-00146
Device Sequence Number1
Product Code LWQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P000037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,health profession
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/07/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/06/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/01/2021
Device Model NumberONXAAP-23
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date08/15/2018
Date Manufacturer Received08/15/2018
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age60 YR
-
-